Literature DB >> 25239371

Neural effects of inflammation, cardiovascular disease, and HIV: Parallel, perpendicular, or progressive?

C L Nemeth1, M Bekhbat1, G N Neigh2.   

Abstract

The pervasive reach of the inflammatory system is evidenced by its involvement in numerous disease states. Cardiovascular disease, marked by high levels of circulating inflammatory mediators, affects an estimated 83.6 million Americans. Similarly, human immunodeficiency virus (HIV) produces a paradoxical state of generalized immune activity despite widespread immunosuppression, and affects 35 million people worldwide. Patients living with HIV (PLWH) suffer from inflammatory conditions, including cardiovascular disease (CVD), at a rate exceeding the general population. In this combined disease state, immune mechanisms that are common to both CVD and HIV may interact to generate a progressive condition that contributes to the exacerbated pathogenesis of the other to the net effect of damage to the brain. In this review, we will outline inflammatory cell mediators that promote cardiovascular risk factors and disease initiation and detail how HIV-related proteins may accelerate this process. Finally, we examine the extent to which these comorbid conditions act as parallel, perpendicular, or progressive sequela of events to generate a neurodegenerative environment, and consider potential strategies that can be implemented to reduce the burden of CVD and inflammation in PLWH.
Copyright © 2014 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AIDS; HIV; cardiovascular; cerebrovascular; immune; inflammation

Mesh:

Substances:

Year:  2014        PMID: 25239371      PMCID: PMC6492036          DOI: 10.1016/j.neuroscience.2014.09.016

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  80 in total

1.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.

Authors:  Thomas A Pearson; George A Mensah; R Wayne Alexander; Jeffrey L Anderson; Richard O Cannon; Michael Criqui; Yazid Y Fadl; Stephen P Fortmann; Yuling Hong; Gary L Myers; Nader Rifai; Sidney C Smith; Kathryn Taubert; Russell P Tracy; Frank Vinicor
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

2.  Prevalence and risk factors of silent cerebral infarction in apparently normal adults.

Authors:  S C Lee; S J Park; H K Ki; H C Gwon; C S Chung; H S Byun; K J Shin; M H Shin; W R Lee
Journal:  Hypertension       Date:  2000-07       Impact factor: 10.190

Review 3.  Cerebral microvascular pathology in aging and Alzheimer's disease.

Authors:  E Farkas; P G Luiten
Journal:  Prog Neurobiol       Date:  2001-08       Impact factor: 11.685

4.  Silent MRI infarcts and the risk of future stroke: the cardiovascular health study.

Authors:  C Bernick; L Kuller; C Dulberg; W T Longstreth; T Manolio; N Beauchamp; T Price
Journal:  Neurology       Date:  2001-10-09       Impact factor: 9.910

Review 5.  Pathogenesis of HIV-associated cardiovascular complications.

Authors:  G Barbaro; S D Fisher; S E Lipshultz
Journal:  Lancet Infect Dis       Date:  2001-09       Impact factor: 25.071

6.  Successful cardiopulmonary resuscitation after cardiac arrest as a "sepsis-like" syndrome.

Authors:  Christophe Adrie; Minou Adib-Conquy; Ivan Laurent; Mehran Monchi; Christophe Vinsonneau; Catherine Fitting; François Fraisse; A Tuan Dinh-Xuan; Pierre Carli; Christian Spaulding; Jean-François Dhainaut; Jean-Marc Cavaillon
Journal:  Circulation       Date:  2002-07-30       Impact factor: 29.690

Review 7.  Monocyte/macrophage traffic in HIV and SIV encephalitis.

Authors:  Woong-Ki Kim; Sarah Corey; Xavier Alvarez; Kenneth Williams
Journal:  J Leukoc Biol       Date:  2003-08-11       Impact factor: 4.962

8.  Cerebral white matter lesions, retinopathy, and incident clinical stroke.

Authors:  Tien Yin Wong; Ronald Klein; A Richey Sharrett; David J Couper; Barbara E K Klein; Duan-Ping Liao; Larry D Hubbard; Thomas H Mosley
Journal:  JAMA       Date:  2002-07-03       Impact factor: 56.272

9.  Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.

Authors:  Nina Friis-Møller; Rainer Weber; Peter Reiss; Rodolphe Thiébaut; Ole Kirk; Antonella d'Arminio Monforte; Christian Pradier; Linda Morfeldt; Silvia Mateu; Matthew Law; Wafaa El-Sadr; Stephan De Wit; Caroline A Sabin; Andrew N Phillips; Jens D Lundgren
Journal:  AIDS       Date:  2003-05-23       Impact factor: 4.177

Review 10.  Inflammatory bio-markers and cardiovascular risk prediction.

Authors:  G J Blake; P M Ridker
Journal:  J Intern Med       Date:  2002-10       Impact factor: 8.989

View more
  10 in total

1.  Glucocorticoid Receptor Function and Cognitive Performance in Women With HIV.

Authors:  Leah H Rubin; Mandakh Bekhbat; Susie Turkson; C Christina Mehta; Pauline M Maki; Kathryn Anastos; Deborah Gustafson; Amanda B Spence; Joel Milam; Felicia C Chow; Kathleen Weber; Gayle Springer; Stephen J Gange; Gretchen N Neigh
Journal:  Psychosom Med       Date:  2022-08-20       Impact factor: 3.864

2.  HIV and symptoms of depression are independently associated with impaired glucocorticoid signaling.

Authors:  Mandakh Bekhbat; C Christina Mehta; Sean D Kelly; Aimee Vester; Ighovwerha Ofotokun; Jennifer Felger; Gina Wingood; Kathryn Anastos; Deborah R Gustafson; Seble Kassaye; Joel Milam; Bradley Aouizerat; Kathleen Weber; Elizabeth T Golub; Michelle Floris Moore; Ralph Diclemente; Margaret Fischl; Mirjam-Colette Kempf; Pauline Maki; Gretchen N Neigh
Journal:  Psychoneuroendocrinology       Date:  2018-06-18       Impact factor: 4.905

3.  Brief Report: Higher Peripheral Monocyte Activation Markers Are Associated With Smaller Frontal and Temporal Cortical Volumes in Women With HIV.

Authors:  Asante R Kamkwalala; Xuzhi Wang; Pauline M Maki; Dionna W Williams; Victor G Valcour; Alexandra Damron; Phyllis C Tien; Kathleen M Weber; Mardge H Cohen; Erin E Sundermann; Vanessa J Meyer; Deborah M Little; Yanxun Xu; Leah H Rubin
Journal:  J Acquir Immune Defic Syndr       Date:  2020-05-01       Impact factor: 3.771

Review 4.  Untangling the Gordian knot of HIV, stress, and cognitive impairment.

Authors:  Arielle N Valdez; Leah H Rubin; Gretchen N Neigh
Journal:  Neurobiol Stress       Date:  2016-02-11

5.  Cardiovascular disease risk among transgender women living with HIV in the United States.

Authors:  Bennett J Gosiker; Catherine R Lesko; Ashleigh J Rich; Heidi M Crane; Mari M Kitahata; Sari L Reisner; Kenneth H Mayer; Rob J Fredericksen; Geetanjali Chander; William C Mathews; Tonia C Poteat
Journal:  PLoS One       Date:  2020-07-20       Impact factor: 3.240

Review 6.  Patho-immune Mechanisms of Hypertension in HIV: a Systematic and Thematic Review.

Authors:  Sepiso K Masenga; Benson M Hamooya; Selestine Nzala; Geoffrey Kwenda; Douglas C Heimburger; Wilbroad Mutale; Sody M Munsaka; John R Koethe; Annet Kirabo
Journal:  Curr Hypertens Rep       Date:  2019-06-04       Impact factor: 5.369

7.  Editorial: Experience-Dependent Neuroplasticity Across the Lifespan: From Risk to Resilience.

Authors:  Erica R Glasper; Gretchen N Neigh
Journal:  Front Behav Neurosci       Date:  2019-01-18       Impact factor: 3.558

8.  Ethnic disparities in estimated cardiovascular disease risk in Amsterdam, the Netherlands : The HELIUS study.

Authors:  W Perini; M B Snijder; R J G Peters; A E Kunst
Journal:  Neth Heart J       Date:  2018-05       Impact factor: 2.380

9.  Biopsychosocial Mechanisms Linking Gender Minority Stress to HIV Comorbidities Among Black and Latina Transgender Women (LITE Plus): Protocol for a Mixed Methods Longitudinal Study.

Authors:  Ashleigh J Rich; Jennifer Williams; Mannat Malik; Andrea Wirtz; Sari Reisner; L Zachary DuBois; Robert Paul Juster; Catherine R Lesko; Nicole Davis; Keri N Althoff; Christopher Cannon; Kenneth Mayer; Ayana Elliott; Tonia Poteat
Journal:  JMIR Res Protoc       Date:  2020-04-13

10.  Occludin, caveolin-1, and Alix form a multi-protein complex and regulate HIV-1 infection of brain pericytes.

Authors:  Silvia Torices; Samantha A Roberts; Minseon Park; Arun Malhotra; Michal Toborek
Journal:  FASEB J       Date:  2020-10-14       Impact factor: 5.834

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.